Colonoscopy - Discussion on the Nordic-European Initiative Trial Report Findings

Slide Presentation

Pdf Summary

ASGE, the American Society for Gastrointestinal Endoscopy, hosted a webinar on October 20, 2022, to discuss and respond to the findings of the NordICC Trial presented by Bretthauer et al. The Nordic-European Initiative on Colorectal Cancer (NordICC Trial) was a pragmatic, randomized trial conducted in Poland, Norway, Sweden, and the Netherlands from 2009 to 2022.<br /><br />The panelists for the webinar included Dr. Bret Petersen, ASGE President and moderator, Dr. Michael Bretthauer, Dr. Michal Kaminski, Dr. Doug Rex, and Dr. Jason Dominitz.<br /><br />The webinar began with a presentation of the NordICC Trial findings by Dr. Michael Bretthauer and Dr. Michal Kaminski. They discussed the reduction in colorectal cancer incidence and mortality rates observed in the trial. They also compared the results between intent-to-treat (ITT) analysis and per-protocol (PP) analysis.<br /><br />Dr. Doug Rex and Dr. Jason Dominitz offered their response to the NordICC Trial findings, discussing the implications and potential limitations of the study.<br /><br />During the panel discussion, the panelists addressed questions from the audience and engaged in a discussion about the study's results and their implications.<br /><br />Dr. Michael Bretthauer and Dr. Michal Kaminski provided their final remarks on the NordICC Trial findings, followed by the ASGE's final remarks by Dr. Doug Rex and Dr. Jason Dominitz.<br /><br />The webinar concluded with Dr. Bret Petersen's concluding remarks and adjournment.<br /><br />Overall, the webinar aimed to provide an in-depth analysis and response to the findings of the NordICC Trial, focusing on the effectiveness of colonoscopy screening in reducing the risks of colorectal cancer and related deaths.

Keywords

ASGE

webinar

NordICC Trial

colorectal cancer

incidence

mortality rates

Doug Rex

Jason Dominitz

panel discussion

colonoscopy screening